References
- World Health Organization (WHO)Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. Updated version, April 2016 Available from: http://apps.who.int/iris/bitstream/10665/205035/1/9789241549615_eng.pdf?ua=1Accessed July 4, 2017
- World Health OrganizationHepatitis C [updated July 2016] Available from: http://www.who.int/mediacentre/factsheets/fs164/en/Accessed July 4, 2017
- PetruzzielloAMariglianoSLoquercioGCozzolinoACacciapuotiCGlobal epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypesWorld J Gastroenterol201622782427678366
- European Centre for Disease Prevention and ControlTechnical report hepatitis B and C in the EU neighborhood: prevalence, burden of disease and screening policies2010 Available from: http://www.ecdc.europa.eu/en/publications/Publications/TER_100914_Hep_B_C%20_EU_neighbourhood.pdfAccessed October 10, 2016
- Mohd HanafiahKGroegerJFlaxmanADWiersmaSTGlobal epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalenceHepatology2013571333134223172780
- MeleATostiMESpadaEMarianoABiancoESEIEVA Collaborative GroupEpidemiology of Acute Viral Hepatitis: Twenty Years of Surveillance through SEIEVA in Italy and a Review of the LiteratureRomeIstituto Superiore di SanitàRapporti Istisan 06/122012
- MarascioNLibertoMCBarrecaGSUpdate on epidemiology of HCV in Italy: focus on the Calabria RegionBMC Infect Dis201414Suppl 5S2
- TorreGLGualanoMRSemyonovLNicolottiNRicciardiWBocciaAHepatitis C virus infection trends in Italy, 1996–2006Hepat Mon20111189590022308154
- MenniniFSMarcellusiAAndreoniMGasbarriniASalomoneSCraxìAHealth policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in ItalyClin Outcomes Res20146303310
- ISS (Istituto Superiore di Sanità) and SEIEVA (Sistema Epidemiologico Integrato dell’Epatite Virale Acuta) Collaborative GroupEpidemiology of acute viral hepatitis in Italy: results of the surveillance through SEIEVA. Annual Report Rome2015 Available from: http://www.iss.it/binary/seie/cont/Tassi_EpatiteC_2015.pdfAccessed July 4, 2017
- Fondazione Italiana per la Ricerca in EpatologiaLibro Bianco AISF 2011; Proposta per un piano nazionale per il controllo delle malattie epatiche; definizione ambiti e possibili interveti [White Book of AISF; Proposal of a national plan for the control of hepatic diseases; definition of scopes and possible interventions2011Accessed May 13, 2014 Available from: http://www.webaisf.org/media/13891/libro-bianco-aisf-2011.pdfAccessed May 13, 2014 Italian
- PerroneVSangiorgiDBudaSDegli EspostiLDisease progression and health care resource consumption in patients affected by hepatitis C virus in real practice settingClin Outcomes Res20168591597
- FooteBSSpoonerLMBelliveauPPBoceprevir: a protease inhibitor for the treatment of chronic hepatitis CAnn Pharmacother2011451085109321828346
- SmithLSNelsonMNaikSWotenJTelaprevir: an NS3/4A protease inhibitor for the treatment of chronic hepatitis CAnn Pharmacother20114563964821558488
- European Medicines AgencyEuropean public assessment reports. [webpage on the Internet] Available http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d124Accessed July 4, 2017
- Mah’moudMACurrent management of hepatitis C virus infectionN C Med J20167718819327154887
- MarcellusiAVitiRCaponeAMenniniFSThe economic burden of HCV-induced diseases in Italy. A probabilistic cost of illness modelEur Rev Med Pharmacol Sci2015191610162026004601
- Demo IstatIstat; Istituto nazionale di statistica. [National institute of statistics] Available at: http://demo.istat.it/pop2016/index.htmlAccessed July 4, 2017 Italian
- AIFA Guideline for the classification and conduction of the observational studies on medicines Available from: https://www.agenziafarmaco.gov.it/ricclin/sites/default/files/files_wysiwyg/files/CIRCULARS/Circular%2031st%20May%202010.pdfAccessed July 4, 2017
- GonnellaJSDanielLGozumMVCallahanCABarnesCADisease Staging Clinical and Coded Criteria. Version 5.26Ann Arbor, MIThomson Medstat2010
- FadiniGPAvogaroADegli EspostiLRisk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB DatabaseEur Heart J2015362454246226112890
- DultzGZeuzemSHepatitis C virusGastroenterol Clin North Am20154480782426600221
- PapatheodoridisGVTsochatzisEHardtkeSWedemeyerHBarriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic reviewLiver Int2014341452146324750532
- LapiFCapogrosso SansoneAMantarroSHepatitis C virus infection: opportunities for an earlier detection in primary careEur J Gastroenterol Hepatol201729327127627849644
- PetruzzielloAMariglianoSLoquercioGCacciapuotiCHepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in EuropeInfect Agent Cancer2016115327752280
- BellentaniSTiribelliCThe spectrum of liver disease in the general population: lesson from the Dionysos studyJ Hepatol20013553153711682041
- AscioneATartaglioneTDi CostanzoGNatural history of chronic hepatitis C virus infectionDig Liver Dis200739Suppl 1S4S717936222
- ChenSLMorganTRThe natural history of hepatitis C virus (HCV) infectionInt J Med Sci200632475216614742
- University of WashingtonHepatits C Online – HCV Epidemiology in the United States. Updated version; February 2017 Available from: http://www.hepatitisc.uw.edu/pdf/screening-diagnosis/epidemiologyus/core-concept/allAccessed July 4, 2017
- RogalSSArnoldRMChapkoMThe patient-provider relationship is associated with hepatitis C treatment eligibility: a prospective mixed-methods cohort studyPLoS One201611e014859626900932
- StroffoliniTSpadaroADi MarcoVCurrent practice of chronic hepatitis B treatment in Southern ItalyEur J Intern Med201223e124e12722726382
- RazaviHElkhouryACElbashaEChronic hepatitis C virus (HCV) disease burden and cost in the United StatesHepatology2013572164217023280550
- WillemseSBRazavi-ShearerDZuureFRThe estimated future disease burden of hepatitis C virus in the Netherlands with different treatment paradigmsNeth J Med20157341743126582807
- ScaloneLFagiuoliSCiampichiniRThe societal burden of chronic liver diseases: results from the COME studyBMJ Open Gastroenterol20152e000025
- VietriJPrajapatiGEl KhouryACThe burden of hepatitis C in Europe from the patients’ perspective: a survey in 5 countriesBMC Gastroenterol2013131623324473
- Istat; Istituto nazionale di statistica [National institute of statistics; homepage] http://www.istat.it/it/Accessed July 4, 2017 Italian
- MarianoAScalia TombaGTostiMESpadaEMeleAEstimating the incidence, prevalence and clinical burden of hepatitis C over time in ItalyScand J Infect Dis200941968969919579149
- AnsaldiFBruzzoneBSalmasoSDifferent seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in ItalyJ Med Virol2005776332733215902713